Stay updated on Relatlimab + Nivolumab Bioavailability Clinical Trial

Sign up to get notified when there's something new on the Relatlimab + Nivolumab Bioavailability Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Relatlimab + Nivolumab Bioavailability Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision: v3.5.4 is now displayed, replacing the previous v3.5.3. This indicates a newer version of the page has been published.
    Difference
    0.1%
    Check dated 2026-05-14T23:08:52.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page updates its revision history to v3.5.3, replacing the previous v3.5.2. This represents a routine metadata update to the study record rather than a substantive change to the study details.
    Difference
    0.1%
    Check dated 2026-04-30T16:53:34.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    - Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:51:39.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-03-18T17:56:20.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This is a minor technical update to the page revision.
    Difference
    0.1%
    Check dated 2026-03-11T15:33:05.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2. The prior funding-lapse notice (v3.4.1) has been removed.
    Difference
    0.5%
    Check dated 2026-02-11T02:14:23.000Z thumbnail image

Stay in the know with updates to Relatlimab + Nivolumab Bioavailability Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Relatlimab + Nivolumab Bioavailability Clinical Trial page.